Publications by authors named "Gavin McDonnell"

Claim this Profile
E
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Jeremy Chataway, Thomas Williams, James Blackstone, Nevin John, Marie Braisher, Gavin McDonnell

Lancet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a multiple sclerosis relapse clinic.
Ger Mullan, Rachael Kee, Fiona Kennedy, Stella Hughes, Gavin V McDonnell

Mult Scler Relat Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories.
Carolyn A Young, David Rog, Basil Sharrack, Suresh K Chhetri, Seema Kalra, Gavin McDonnell

J Neurol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialty.
Tarunya Arun, Kate Petheram, Emma Tallantyre, Helen Ford, Jeremy Chataway, Gavin McDonnell

Mult Scler Relat Disord· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-surgical spinal cord infarction: case series & long-term follow-up of functional outcome.
Fionán McBride, Jane Anketell, Gavin V McDonnell, Suzanne Maguire, Karen M Doherty

Spinal Cord Ser Cases· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
James Blackstone, Thomas Williams, Jennifer M Nicholas, Ekaterina Bordea, Floriana De Angelis, Gavin McDonnell

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world persistence of multiple sclerosis disease-modifying therapies.
Emma C Tallantyre, Ruth Dobson, Joseph L J Froud, Frederika A St John, Valerie M Anderson, Gavin V McDonnell

Eur J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Cone Density Is Associated with Multiple Sclerosis.
Gemma McIlwaine, Lajos Csincsik, Rachel Coey, Luping Wang, Denise Fitzgerald, Gavin McDonnell

Ophthalmol Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
Izanne Roos, Stella Hughes, Gavin McDonnell, Charles B Malpas, Sifat Sharmin

JAMA Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis.
Rachael Kee, Michelle Naughton, Gavin V McDonnell, Owain W Howell, Denise C Fitzgerald

Biomedicines· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of smoking cessation on multiple sclerosis disease progression.
Jeff Rodgers, Tim Friede, Frederick W Vonberg, Cris S Constantinescu, Alasdair Coles, Gavin V McDonnell

Brain· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis.
Michelle Naughton, Jill Moffat, George Eleftheriadis, Nira de la Vega Gallardo, Andrew Young, Gavin McDonnell

J Neuroinflammation· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification.
Lucia V Schottlaender, Rosella Abeti, Zane Jaunmuktane, Carol Macmillan, Viorica Chelban, Gavin McDonnell

Am J Hum Genet· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-perceived risks of MS DMTs: Problems of communication and risk management?
Gavin V McDonnell, James J Marriott

Neurology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview study.
Elaine Cameron, David Rog, Gavin McDonnell, James Overell, Owen Pearson

Mult Scler Relat Disord· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
Ryan J Bevan, Rhian Evans, Lauren Griffiths, Lewis M Watkins, Mark I Rees, Gavin McDonnell

Ann Neurol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Free health care, great data, and new clues on multiple sclerosis.
Gary M Franklin, Gavin McDonnell

Neurology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet in multiple sclerosis: Science takes a seat at the table.
James F Sumowski, Gavin V McDonnell, Dennis Bourdette

Neurology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities in MS are associated with treatment intolerance and disability.
Gavin V McDonnell, Jeffrey A Cohen

Neurology· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Gavin V McDonnell, Amy Bennett, Alexander Rae-Grant, Christopher Bever

Neurology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helping patients and the emergency department: enhanced patient care and reduced hospital admission rates with a pilot rapid access neurology clinic (RANC).
Thomas Peukert, Stella Hughes, Richard Wilson, Stephen Hunt, Gavin McDonnell

Clin Med (Lond)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Stella E Hughes, Tim Spelman, Orla M Gray, Cavit Boz, Maria Trojano, Gavin McDonnell

Mult Scler· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teaching NeuroImages: facial diplegia due to neuroborreliosis.
Jamie Campbell, John McNamee, Peter Flynn, Gavin McDonnell

Neurology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Tumefactive multiple sclerosis lesions under fingolimod treatment.
Michael O Kinney, Gavin McDonnell

Neurology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
Stella Hughes, Timothy Spelman, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Gavin McDonnell

J Neurol Neurosurg Psychiatry· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis